Nanoscope Therapeutics to Present at Advanced Therapies USA 2026

Nanoscope Therapeutics will attend the Advanced Therapies USA 2026 event in Boston. The company plans to utilize the platform to share updates regarding its pipeline of ocular gene therapies and clinical progress.

The conference serves as a meeting point for stakeholders in the cell and gene therapy sector. Nanoscope’s presence reflects its ongoing efforts to communicate data from its clinical trials to medical professionals and industry analysts.

Following a recent clarification of its conference schedule, the company aims to engage with the scientific community regarding its therapeutic platforms. The event remains a key venue for firms looking to establish partnerships and demonstrate advancements in genetic medicine.